Intellectual Property India Publishes Patent Application for 'Formulations For Anti-C1q Antibodies' Filed by Annexon, Inc.

MUMBAI, India, April 18 -- Intellectual Property India has published a patent application (202517024604 A) filed by Annexon, Inc., Brisbane, U.S.A., on March 19, for 'formulations for anti-c1q antibodies.'

Inventor(s) include Oliyai, Cecilia; and Thai, Khoi.

The application for the patent was published on April 18, under issue no. 16/2025.

According to the abstract released by the Intellectual Property India: "The present disclosure is generally directed to pharmaceutical compositions comprising anti-C1q antibodies and methods of making and using such compositions. In certain embodiments, such compositions are high concentration anti-C1q antibody formulations that exhibit low viscosity and high stability and can therefore be conveniently...